Figure 2From: Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? The scatter plot represents the baseline measurements using irRC simulating RECIST1.0 and irRC simulating RECIST1.1. A significant correlation was observed between baseline measurements using two criteria (Spearman correlation coefficient, 0.951 [95% CI: 0.93-0.97]).Back to article page